NuGen Medical Devices Inc
XTSX:NGMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NuGen Medical Devices Inc
Cost of Revenue
NuGen Medical Devices Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NuGen Medical Devices Inc
XTSX:NGMD
|
Cost of Revenue
-CA$487.9k
|
CAGR 3-Years
-121%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Rapid Dose Therapeutics Corp
CNSX:DOSE
|
Cost of Revenue
-CA$905.1k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-70%
|
CAGR 10-Years
N/A
|
|
|
Covalon Technologies Ltd
XTSX:COV
|
Cost of Revenue
-CA$15.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-17%
|
|
|
I
|
Imaging Dynamics Co Ltd
XTSX:IDL
|
Cost of Revenue
-CA$36.4k
|
CAGR 3-Years
33%
|
CAGR 5-Years
8%
|
CAGR 10-Years
34%
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Cost of Revenue
-$7.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-14%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Cost of Revenue
-CA$728k
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
NuGen Medical Devices Inc
Glance View
Nugen Medical Devices, Inc. is a capital pool company. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-05-28. The Company, through its subsidiary EPG Global Ltd., is focused on developing and commercializing drug delivery technologies. EPG Global Ltd. has commercialized needle-free injection systems for the administration of subcutaneous medication.
See Also
What is NuGen Medical Devices Inc's Cost of Revenue?
Cost of Revenue
-487.9k
CAD
Based on the financial report for Dec 31, 2024, NuGen Medical Devices Inc's Cost of Revenue amounts to -487.9k CAD.
What is NuGen Medical Devices Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-121%
Over the last year, the Cost of Revenue growth was -193%. The average annual Cost of Revenue growth rates for NuGen Medical Devices Inc have been -121% over the past three years .
